LYPLAL1 and cancer: Analysis of TCGA data showed that MIR181A2HG was highly expressed in thyroid cancer, and LYPLAL1-DT, EIF2AK3-DT and LINC00667 were suppressed in cancer tissue (Figure 8(A–C)).